Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.840
-0.075 (-3.92%)
Jun 14, 2024, 11:04 AM EDT - Market open

Alterity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Year Current20232022202120202019 2018 - 2004
Market Capitalization
141125441712
Upgrade
Market Cap Growth
--54.13%-44.28%155.51%46.89%-30.25%
Upgrade
Enterprise Value
50023112
Upgrade
PE Ratio
-1.21-1.18-2.75-3.82-1.86-1.35
Upgrade
PB Ratio
1.170.721.001.923.491.01
Upgrade
P/FCF Ratio
-1.02-0.81-2.84-3.38-2.64-1.19
Upgrade
P/OCF Ratio
-1.02-0.81-2.86-3.38-2.65-1.19
Upgrade
EV/EBITDA Ratio
---0.05-1.99-1.18-0.18
Upgrade
EV/EBIT Ratio
-0.21-0.04-0.05-1.99-1.18-0.18
Upgrade
EV/FCF Ratio
-0.18-0.03-0.05-1.76-1.67-0.16
Upgrade
Debt / Equity Ratio
--0.000.000.00-
Upgrade
Debt / EBITDA Ratio
---0.010.000.00-
Upgrade
Debt / FCF Ratio
---0.010.000.00-
Upgrade
Quick Ratio
4.075.586.7910.563.415.79
Upgrade
Current Ratio
4.896.177.0710.923.625.98
Upgrade
Return on Equity (ROE)
-53.70%-47.40%-39.00%-81.40%-113.50%-75.60%
Upgrade
Return on Assets (ROA)
-44.20%-40.20%-34.30%-70.40%-90.30%-63.90%
Upgrade
Return on Capital (ROIC)
-95.16%-81.40%-57.96%-64.13%-194.05%-107.20%
Upgrade
Earnings Yield
-61.36%-84.66%-36.38%-26.15%-53.88%-74.10%
Upgrade
FCF Yield
-71.01%-122.90%-35.19%-29.62%-37.83%-83.85%
Upgrade
Buyback Yield / Dilution
-17.08%-0.91%-41.79%-89.62%-45.33%-15.34%
Upgrade
Total Shareholder Return
-17.08%-0.91%-41.79%-89.62%-45.33%-15.34%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).